TP53 and Miyoshi myopathy: The concept of double hit and triple hit MM further represents another approach to risk-stratify newly diagnosed MM patients based on their number of high-risk abnormalities such as t(4;14), t(14;16), t(14;20), del(17p), p53 mutation, gain (1q) and del(1p) [66].